Patent ID: 11931408
Assignee: BAYLOR COLLEGE OF MEDICINE
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G  Y | IPC A  G

Claim 1:
2. A composition comprising an ex vivo expanded, donor-derived, polyclonal population of CD4+ and CD8+ virus-specific human T cells (VSTs) reactive against multiple immunodominant antigens from two or more respiratory viruses, wherein the viruses comprise hMPV and human PIV3, wherein the VSTs comprise T cells reactive to one or more libraries of peptides comprising peptides that overlap in sequence to span part or all of the multiple immunodominant antigens from hMPV and PIV3, wherein the multiple immunogenic antigens from hMPV are F, N, M2-1, and M, and wherein the multiple immunogenic antigens from PIV3 comprise M, HN, and N.